Biochemical and Genetic Analysis of yFACT, A Novel Nucleosome Reorganizing Factor

新型核小体重组因子 yFACT 的生化和遗传分析

基本信息

  • 批准号:
    7254753
  • 负责人:
  • 金额:
    $ 30.12万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-03-01 至 2010-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Large eukaryotic genomes must be packaged as chromatin to keep them organized and stable, but this generally inhibits accessibility to the DNA. Controlling transcription and DMA replication therefore requires the ability to selectively overcome this chromatin barrier. We have identified a factor called yFACT in yeast cells that uses a novel mechanism to diminish the inhibitory effects of chromatin. Unlike the better- characterized remodeling factors that use energy derived from ATP hydrolysis to reposition nucleosomes, yFACT changes the structure of individual nucleosomes without hydrolysing ATP or changing the location of the nucleosomes. We call this novel mechanism "nucleosome reorganization" to distinguish it from remodeling. yFACT is required for both transcription and replication. The goal of this proposal is to analyze the mechanism of nucleosome reorganization and to determine how this reorganizing activity participates in a variety of distinct steps in transcription and replication in living yeast cells. yFACT must interact with many different proteins to accomplish these diverse functions. The first aim of the proposal is to better characterize the interaction between yFACT and two of its known partners, RPA and histones, and then to determine how this binding contributes to the range of yFACT functions. RPA is a key factor in DNA replication and histones compose the protein core of nucleosomes, so these interactions are likely to be central to the diverse functions of yFACT. Models for how these interactions contribute to replication, repair, and transcription are proposed and tested. The second aim is to better characterize the mechanism of nucleosome reorganization using purified components. The reorganized state will be probed using nucleases, the stability of reorganized nucleosomes will be tested, and the proximity of components to one another will be mapped. Finally, chromatin immunoprecipitation, tests of genetic stability, and 2-D gels will be used to address how mutations in yFACT components affect key intermediates in transcription and replication in living cells. The ability to make accurate copies of DNA, either as RNA to allow normal cellular metabolism or as DNA for segregation to progeny, is fundamentally important. yFACT is a vital and novel component of both processes, so studying it provides insight into several distinct central pathways simultaneously.
描述(由申请人提供):大的真核生物基因组必须包装成染色质以保持它们的组织和稳定,但这通常会抑制DNA的可及性。因此,控制转录和DNA复制需要选择性地克服这种染色质屏障的能力。我们在酵母细胞中发现了一种称为yFACT的因子,它使用一种新的机制来减少染色质的抑制作用。与使用来自ATP水解的能量来重新定位核小体的更好表征的重塑因子不同,yFACT改变单个核小体的结构而不水解ATP或改变核小体的位置。我们称这种新机制为“核小体重组”,以区别于重塑。转录和复制都需要yFACT。该提案的目标是分析核小体重组的机制,并确定这种重组活动如何参与活酵母细胞中转录和复制的各种不同步骤。yFACT必须与许多不同的蛋白质相互作用以实现这些不同的功能。该提案的第一个目的是更好地表征yFACT与其两个已知伙伴RPA和组蛋白之间的相互作用,然后确定这种结合如何有助于yFACT功能的范围。RPA是DNA复制中的关键因子,组蛋白构成核小体的蛋白质核心,因此这些相互作用可能是yFACT的多种功能的核心。这些相互作用如何有助于复制,修复和转录模型的建议和测试。第二个目的是更好地表征核小体重组的机制,使用纯化的成分。重组状态将使用核酸酶探测,重组核小体的稳定性将被测试,并且组分彼此的接近度将被映射。最后,染色质免疫沉淀,遗传稳定性测试和2-D凝胶将用于解决yFACT组件中的突变如何影响活细胞中转录和复制的关键中间体。制造准确的DNA拷贝的能力,无论是作为允许正常细胞代谢的RNA,还是作为分离到后代的DNA,都是至关重要的。yFACT是这两个过程的重要和新颖的组成部分,因此研究它可以同时深入了解几个不同的中心途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Timothy G Formosa其他文献

Timothy G Formosa的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Timothy G Formosa', 18)}}的其他基金

Structure, mechanism, and function of the histone chaperones Spt6 and FACT
组蛋白伴侣 Spt6 和 FACT 的结构、机制和功能
  • 批准号:
    9265478
  • 财政年份:
    2016
  • 资助金额:
    $ 30.12万
  • 项目类别:
QUESTION OR TRAINING REQUEST FOR THE YEAST RESOURCE CENTER
对酵母资源中心的问题或培训请求
  • 批准号:
    7957701
  • 财政年份:
    2009
  • 资助金额:
    $ 30.12万
  • 项目类别:
Biochemical & Genetic Analysis of Yeast SPN
生化
  • 批准号:
    6850813
  • 财政年份:
    2002
  • 资助金额:
    $ 30.12万
  • 项目类别:
Biochemical and Genetic Analysis of yFACT, A Novel Nucleosome Reorganizing Factor
新型核小体重组因子 yFACT 的生化和遗传分析
  • 批准号:
    7148488
  • 财政年份:
    2002
  • 资助金额:
    $ 30.12万
  • 项目类别:
Biochemical and Genetic Analysis of yFACT, A Novel Nucleosome Reorganizing Factor
新型核小体重组因子 yFACT 的生化和遗传分析
  • 批准号:
    8450938
  • 财政年份:
    2002
  • 资助金额:
    $ 30.12万
  • 项目类别:
Biochemical, Genetic, and Genomic Analysis of Nucleosome Reorganization by FACT
通过 FACT 进行核小体重组的生化、遗传学和基因组分析
  • 批准号:
    9908077
  • 财政年份:
    2002
  • 资助金额:
    $ 30.12万
  • 项目类别:
Biochemical and Genetic Analysis of yFACT, A Novel Nucleosome Reorganizing Factor
新型核小体重组因子 yFACT 的生化和遗传分析
  • 批准号:
    7641050
  • 财政年份:
    2002
  • 资助金额:
    $ 30.12万
  • 项目类别:
Biochemical and Genetic Analysis of yFACT, A Novel Nucleosome Reorganizing Factor
新型核小体重组因子 yFACT 的生化和遗传分析
  • 批准号:
    9038371
  • 财政年份:
    2002
  • 资助金额:
    $ 30.12万
  • 项目类别:
Biochemical, Genetic, and Genomic Analysis of Nucleosome Reorganization by FACT
通过 FACT 进行核小体重组的生化、遗传学和基因组分析
  • 批准号:
    9756636
  • 财政年份:
    2002
  • 资助金额:
    $ 30.12万
  • 项目类别:
Biochemical and Genetic Analysis of yFACT, A Novel Nucleosome Reorganizing Factor
新型核小体重组因子 yFACT 的生化和遗传分析
  • 批准号:
    8241952
  • 财政年份:
    2002
  • 资助金额:
    $ 30.12万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 30.12万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 30.12万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.12万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.12万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 30.12万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 30.12万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.12万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 30.12万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 30.12万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 30.12万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了